Market Overview

UPDATE: Deutsche Bank Initiates Coverage on CVS Caremark on Industry Overhang Concerns

Related CVS
CVS Health Announces Formulary and Therapy Strategy for PCSK9 Inhibitors
CVS Crashed On Guidance, But Leerink Remains Bullish
CVS Is A Great Low-Risk Bet For 'Buy And Hold' Investors (Seeking Alpha)

In a report published Thursday, Deutsche Bank analyst George Hill initiated coverage on CVS Caremark Corporation (NYSE: CVS) with a Hold rating and $71.00 price target.

In the report, Deutsche Bank noted, “We are initiating coverage of CVS Caremark (CVS) with a Hold rating. CVS is a combination of one of the largest retail pharmacies and one of the largest PBMs in the United States. At the current share price, we fear industry overhangs related to the PBM could begin to weigh more heavily on the company's multiple, and at its current size, it is difficult to envision a catalyst that moves the needle to drive faster earnings growth or multiple expansion. Even a global generics purchasing deal, by our math, barely moves the needle for CVS.”

CVS Caremark closed on Wednesday at $65.42.

Latest Ratings for CVS

Nov 2015JP MorganMaintainsOverweight
Nov 2015OppenheimerMaintainsOutperform
Aug 2015OppenheimerMaintainsOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Deutsche Bank George HillAnalyst Color Initiation Analyst Ratings


Related Articles (CVS)

View Comments and Join the Discussion!

Get Benzinga's Newsletters